We demonstrate that KHK is upregulated in pancreatic cancer and show that genetic ablation of KHKC is sufficient to delay the onset and the development of PDAC KPC-driven PDAC in vivo by downregulating MAPK and mTOR signaling. The gene discussed is KHK; the disease is pancreatic neoplasm.